Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Enterovirus, Bovine
Transformation, Bacterial
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Conservation of bronchiolar wall area during constriction and dilation of human airways.
Pharmacogenomic considerations for medications in the perioperative setting.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacogenomic considerations for medications in the perioperative setting.
Pharmacogenomic considerations for medications in the perioperative setting. Pharmacogenomics. 2019 07; 20(11):813-827.
View in:
PubMed
subject areas
Drug-Related Side Effects and Adverse Reactions
Genetic Predisposition to Disease
Genetic Testing
Humans
Perioperative Care
Pharmacogenetics
Pharmacogenomic Testing
Precision Medicine
authors with profiles
Jeffrey Apfelbaum
Mark J. Ratain
Sajid S. Shahul
Peter H. O'Donnell
David Dickerson